03.17.25 -- STREAM Edition: Innovations, Strategies, And Tech In Today's Biopharma And Drug Development

Review case studies and explore the complexities of oligonucleotide design, GMP standards for ADCs, and how developability can play a significant role in selecting ADC leads with high potential.

Discover how these groundbreaking Oral GLP-1 Analogs therapies are reshaping obesity management and addressing key challenges in formulation and delivery.

Gain valuable insights into advanced methods and analysis techniques for high-order structure, physiochemical characterization, cell-based and biochemical assays, and more.

Delve into the evolving landscape of pediatric dosage forms, with a focus on how ODTs are emerging as a specialized and practical drug delivery system for children.

Consider a cutting-edge service in powder blending, encapsulation, tablet compression, and on-site laboratory testing that meets the highest standards to ensure exceptional quality and compliance.

Experts share how their teams collaborate and tailor solutions to meet sponsors' unique needs, highlighting real examples of implementing innovative strategies to ensure projects stay on track.

It’s great to outsource to the most experienced CDMOs. But your program is indeed novel. How do you close the knowledge gap with your partner? We have some suggestions.

Explore the role of eData in automating processes, enabling predictive analytics, improving supply chain resilience, and adopting standardized digital platforms in biopharma manufacturing.

Myoung Goo Kim, Chemistry R&D Manager in High Point, NC, is a recognized expert in process chemistry, specializing in API manufacturing for Cambrex’s clients.

The OligoProcess™ synthesizer is a high-capacity oligonucleotide production system designed for clinical phase and commercial-scale manufacturing, with a synthesis range from 10 to 1800 mmol.